Chinese Hepatitis B Vaccine Industry - Deep Research Report 2013

DUBLIN, Nov. 26, 2013 /PRNewswire/-- Research and Markets (http://www.researchandmarkets.com/research/vjp9tg/2013_deep) has announced the addition of the "Chinese Hepatitis B Vaccine Industry - Deep Research Report 2013" report to their offering.

(Logo: http://photos.prnewswire.com/prnh/20130307/600769)

This 2013 Deep Research Report is a professional and in-depth research report on the Chinese Hepatitis B Vaccine industry. This report firstly discusses Hepatitis B vaccine definition, classification, industry chain, manufacturing technology and product specifications. The report then gives statistics on major Chinese Hepatitis B vaccine manufacturers including details on capacity, production, supply, demand, shortage, selling price, cost, gross margin and production value.

The report gives information on 8 Chinese manufacturers such as basic company information, production price, cost, gross margin, production value and Chinese market share. In the end, this report discusses the 10million pieces/year Hepatitis B vaccine project feasibility analysis and investment return analysis, and gives related research conclusions and development trend analysis.

Key Topics Covered:

1 Hepatitis B Vaccine Industry Overview
1.1 Definition
1.2 Classification Application Work Principle and Related Content
1.3 Industry Chain Structure
1.4 Market Status and Development Trend
1.5 Policy Analysis

2 Hepatitis B Vaccine Manufacturing Process and Cost Analysis
2.1 Product Speficiation
2.2 Manufacturing Process Analysis
2.3 Cost Structure Analysis
2.4 Raw Materials and Equipments Overview
2.5 Technical Trend and Difficulties

3 Hepatitis B Vaccine Production Supply Sales Demand Market Status and Forecast
3.1 Hepatitis B Vaccine Capacity and Production
3.2 Hepatitis B Vaccine Different Type(Saccharomyces Cerevisiae:5ug 10ug 20ug 60ug,CHO Cell:10ug 20ug,Hansenula Polymorpha:10ug) Capacity and Production
3.3 Children Adult Type Hepatitis B Vaccine Production Overview
3.4 Beijing Shenzhen Liaoning Hebei Shandong Henan etc Different Regions Hepatitis B Vaccine Production Overview
3.5 Hepatitis B Vaccine Capacity Utilization Rate Analysis
3.6 Hepatitis B Vaccine Demand Overview
3.7 Hepatitis B Vaccine Supply Demand Shortage
3.8 Hepatitis B Vaccine Cost Price Production Value Gross Margin
3.9 Hepatitis B Vaccine Import Export Consumption
3.10 Hepatitis B Vaccine Batch Release Number Statistics

4 Hepatitis B Vaccine Key Manufacturers
4.1 Beijing Tiantan Biological Products Co.,Ltd (600161)
4.2 Shenzhen Kaitai Biological
4.3 Dalian Hissen Biological
4.4 NCPC GeneTech Biotechnology
4.5 Beijing Huaerdun Biotechnology
4.6 Hualan Biological(002007)
4.7 GSK
4.8 Berna Biotech

5 Hepatitis B Vaccine New Project Investment Feasibility Analysis
5.1 Hepatitis B Vaccine New Project SWOT Analysis
5.2 10 Million Pieces/Year Hansenula Polymorpha YeastHepatitis B Vaccine (Type:10ug) Project Investment Feasibility Analysis

6 Hepatitis B Vaccine Industry Research Conclusions

Companies Mentioned

• Berna Biotech
• Beijing Huaerdun Biotechnology
• Beijing Tiantan Biological Products Co.,Ltd (600161)
• Dalian Hissen Biological
• GSK
• Hualan Biological(002007)
• NCPC GeneTech Biotechnology
• Shenzhen Kaitai Biological

For more information visit http://www.researchandmarkets.com/research/vjp9tg/2013_deep

Media Contact: Laura Wood , +353-1-481-1716, press@researchandmarkets.net

SOURCE Research and Markets